Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ‐46281222. (13th January 2016)
- Record Type:
- Journal Article
- Title:
- Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ‐46281222. (13th January 2016)
- Main Title:
- Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ‐46281222
- Authors:
- Doornbos, Maarten L J
Pérez‐Benito, Laura
Tresadern, Gary
Mulder‐Krieger, Thea
Biesmans, Ilse
Trabanco, Andrés A
Cid, Jose María
Lavreysen, Hilde
IJzerman, Adriaan P
Heitman, Laura H - Abstract:
- Abstract : Background and Purpose: Allosteric modulation of the mGlu2 receptor is a potential strategy for treatment of various neurological and psychiatric disorders. Here, we describe the in vitro characterization of the mGlu2 positive allosteric modulator (PAM) JNJ‐46281222 and its radiolabelled counterpart [ 3 H]‐JNJ‐46281222. Using this novel tool, we also describe the allosteric effect of orthosteric glutamate binding and the presence of a bound G protein on PAM binding and use computational approaches to further investigate the binding mode. Experimental Approach: We have used radioligand binding studies, functional assays, site‐directed mutagenesis, homology modelling and molecular dynamics to study the binding of JNJ‐46281222. Key Results: JNJ‐46281222 is an mGlu2 ‐selective, highly potent PAM with nanomolar affinity ( K D = 1.7 nM). Binding of [ 3 H]‐JNJ‐46281222 was increased by the presence of glutamate and greatly reduced by the presence of GTP, indicating the preference for a G protein bound state of the receptor for PAM binding. Its allosteric binding site was visualized and analysed by a computational docking and molecular dynamics study. The simulations revealed amino acid movements in regions expected to be important for activation. The binding mode was supported by [ 3 H]‐JNJ‐46281222 binding experiments on mutant receptors. Conclusion and Implications: Our results obtained with JNJ‐46281222 in unlabelled and tritiated form further contribute to ourAbstract : Background and Purpose: Allosteric modulation of the mGlu2 receptor is a potential strategy for treatment of various neurological and psychiatric disorders. Here, we describe the in vitro characterization of the mGlu2 positive allosteric modulator (PAM) JNJ‐46281222 and its radiolabelled counterpart [ 3 H]‐JNJ‐46281222. Using this novel tool, we also describe the allosteric effect of orthosteric glutamate binding and the presence of a bound G protein on PAM binding and use computational approaches to further investigate the binding mode. Experimental Approach: We have used radioligand binding studies, functional assays, site‐directed mutagenesis, homology modelling and molecular dynamics to study the binding of JNJ‐46281222. Key Results: JNJ‐46281222 is an mGlu2 ‐selective, highly potent PAM with nanomolar affinity ( K D = 1.7 nM). Binding of [ 3 H]‐JNJ‐46281222 was increased by the presence of glutamate and greatly reduced by the presence of GTP, indicating the preference for a G protein bound state of the receptor for PAM binding. Its allosteric binding site was visualized and analysed by a computational docking and molecular dynamics study. The simulations revealed amino acid movements in regions expected to be important for activation. The binding mode was supported by [ 3 H]‐JNJ‐46281222 binding experiments on mutant receptors. Conclusion and Implications: Our results obtained with JNJ‐46281222 in unlabelled and tritiated form further contribute to our understanding of mGlu2 allosteric modulation. The computational simulations and mutagenesis provide a plausible binding mode with indications of how the ligand permits allosteric activation. This study is therefore of interest for mGlu2 and class C receptor drug discovery. … (more)
- Is Part Of:
- British journal of pharmacology. Volume 173:Number 3(2016:Feb.)
- Journal:
- British journal of pharmacology
- Issue:
- Volume 173:Number 3(2016:Feb.)
- Issue Display:
- Volume 173, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 173
- Issue:
- 3
- Issue Sort Value:
- 2016-0173-0003-0000
- Page Start:
- 588
- Page End:
- 600
- Publication Date:
- 2016-01-13
- Subjects:
- Pharmacology -- Periodicals
Chemotherapy -- Periodicals
Drug Therapy -- Periodicals
Pharmacology -- Periodicals
615.1 - Journal URLs:
- http://bibpurl.oclc.org/web/21844 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381/issues ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=282&action=archive ↗
http://onlinelibrary.wiley.com/ ↗
http://www.nature.com/bjp/index.html ↗ - DOI:
- 10.1111/bph.13390 ↗
- Languages:
- English
- ISSNs:
- 0007-1188
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2314.700000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9208.xml